Announcements Trials
Browse Landscape

Phase

Phase 2 54Phase 1 33Phase 1/2 26Phase 3 24Phase NA 4Phase 4 4Phase 2/3 3

Status

Completed 3

Sponsor Class

OTHER 31NIH 8NETWORK 6INDUSTRY 3OTHER_GOV 2

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 1Head & Neck 1Gastrointestinal 1

Conditions

Sarcoma 1Head and Neck Neoplasms 1Esophageal Neoplasms 1Adenocarcinoma 1

Interventions

Cisplatin 29Carboplatin 28Gemcitabine 27Paclitaxel 26pembrolizumab 24Capecitabine 16Pemetrexed 15Bevacizumab 15Docetaxel 14Oxaliplatin 13Fluorouracil 12Drug Therapy 12Nivolumab 10130-nm albumin-bound paclitaxel 9Trastuzumab 8anlotinib 7Injections 7Rituximab 6venetoclax 5atezolizumab 5Temozolomide 5Leucovorin 5Ipilimumab 5Lenalidomide 4Irinotecan 4Interferon alpha-2 4Folfox protocol 4Dexamethasone 4Azacitidine 4Albumin-Bound Paclitaxel 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2/3 × INDUSTRY × Radiotherapy × Clear all
NCT01249352 2025-03-31

NICE

Eurofarma Laboratorios S.A.

Phase 2/3 Completed
104 enrolled
Gastrointestinal

Adenocarcinoma, Esophageal Neoplasms

NCT02379845 2021-04-06

NBTXR3 Crystalline Nanoparticles and Radiation Therapy in Treating Randomized Patients in Two Arms With Soft Tissue Sarcoma of the Extremity and Trunk Wall

Nanobiotix

Phase 2/3 Completed
180 enrolled
Sarcoma

Sarcoma

NCT00261703 2012-05-11

Docetaxel in Head and Neck Cancer

Sanofi

Phase 2/3 Completed
439 enrolled
Head & Neck

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡